InsidersTradesSigma
Follow the 일신바이오 stock price and the full management transaction log of the company, a publicly traded company based in South Korea. Shares are listed on KR KR, under the supervision of DART (FSS). Operating in the Health Care sector, 일신바이오 has published 7 insider filings. The latest transaction was reported on 4 June 2026 (Purchase). Among the most active insiders: 홍성대. The full history is openly available.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
7 of 7 declarations
Ilshin Bio is in the healthcare and pharmaceutical sector, listed on the XKRX market. The company specializes in the development of biopharmaceutical products.